| Current Price | $0.97 | Mkt Cap | $83.7M |
|---|---|---|---|
| Open | $0.91 | P/E Ratio | 0.00 |
| Prev. Close | $0.90 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $0.91 - $0.99 | Volume | 1,873,865 |
| 52-Wk Range | $0.82 - $0.99 | Avg. Daily Vol. | 580,440 |
| Current Price | $0.97 | Mkt Cap | $83.7M |
|---|---|---|---|
| Open | $0.91 | P/E Ratio | 0.00 |
| Prev. Close | $0.90 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $0.91 - $0.99 | Volume | 1,873,865 |
| 52-Wk Range | $0.82 - $0.99 | Avg. Daily Vol. | 580,440 |
The best Bull and Bear pitches based on recency and number of recommendations.
RA Capital - Peter Kolchinsky a Ph.D in Virology from Harvard has bought millions of shares within the last qtr. His track record suggests that TRVN will be a big winner.RA Capital posting third quarter returns of 51.5% and 1-year returns of… More
Read the most recent pitches from players about TRVN.
Recs
superstar
(99.95)
Submitted: 10/10/2018 10:58:37 AM :
Start Price:
$0.91
NASDAQ:TRVN Score:
-8.65
Loading up the truck!
Recs
btechrisk11
(< 20)
Submitted: 4/15/2018 10:40:23 PM :
Start Price:
$1.63
NASDAQ:TRVN Score:
-63.42
pain treatment up for approval that is a novel biased ligand for opioid receptor. Potential for opioid-like pain relief with less side effects. Its an injectable so limited to hospital use but could be big if approved.
Recs
CM0330
(< 20)
Submitted: 7/18/2016 10:34:44 PM :
Start Price:
$6.67
NASDAQ:TRVN Score:
-137.69
TRVN has the chance to revolutionize pain management, and how doctors administer medicine to deal with recovery for surgical procedures. WIth preliminary data from thier test trials looking strong, I look for the stock to break out in the low teens by early 2017, and potentially take off from there on once more positive data has been obtained.
Find the members with the highest scoring picks in TRVN.
anchak (99.93) Score: +119.31
The Score Leader is the player with the highest score across all their picks in TRVN.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| superstar | 99.95 | 10/10/2018 |
|
5Y | $0.91 | +7.22% | +15.87% | -8.65 | 1 Comment | |
| rt83 | 25.61 | 9/12/2018 |
|
5Y | $1.63 | -40.09% | +13.88% | -53.97 | 0 Comment | |
| redfox18 | 99.91 | 3/21/2019 |
|
5Y | $1.77 | -44.97% | +16.36% | -61.33 | 0 Comment | |
| btechrisk11 | < 20 | 4/16/2018 |
|
1Y | $1.63 | -40.27% | +23.15% | -63.42 | 1 Comment | |
| risktech | 40.66 | 3/29/2018 |
|
5Y | $1.73 | -43.72% | +25.93% | -69.65 | 0 Comment | |
| sunvestor7 | 37.89 | 10/17/2017 |
|
5Y | $1.85 | -47.37% | +28.73% | -76.10 | 0 Comment | |
| retirebefore50 | < 20 | 10/3/2018 |
|
5Y | $3.46 | -71.83% | +12.82% | -84.65 | 0 Comment | |
| manirg | < 20 | 7/31/2017 |
|
5Y | $2.61 | -62.70% | +33.25% | -95.95 | 0 Comment | |
| Bigeric98 | 99.91 | 3/30/2017 |
|
1Y | $3.74 | -73.97% | +39.28% | -113.25 | 0 Comment | |
| dancon7 | 64.20 | 3/3/2017 |
|
3Y | $4.13 | -76.43% | +38.06% | -114.49 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
